Author:
Mortensen Eric M.,Restrepo Marcos I.,Anzueto Antonio
Publisher
Springer Berlin Heidelberg
Reference74 articles.
1. Almog, Y. (2003). Statins, inflammation, and sepsis: Hypothesis. Chest, 124, 740–743.
2. Almog, Y., Shefer, A., Novack, V., Maimon, N., Barski, L., Eizinger, M., Friger, M., Zeller, L., and Danon, A. (2004). Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation, 110, 880–885.
3. Almog, Y., Novack, V., Eisinger, M., Porath, A., Novack, L., and Gilutz, H. (2007). The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases. Crit Care Med, 35, 372–378.
4. Ando, H., Takamura, T., Ota, T., Nagai, Y., and Kobayashi, K. (2000). Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther, 294, 1043–1046.
5. Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M.R. (2001a). Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med, 29, 1303–1310.